Загрузка...
Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer
Development of cisplatin-resistance is an obstacle in non-small cell lung cancer (NSCLC) therapeutics. To investigate which molecules are associated with cisplatin-resistance, we analyzed expression profiles of several DNA repair and anti-apoptosis associated molecules in parental (A549P and H157P)...
Сохранить в:
| Опубликовано в: : | Cancer Biol Ther |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653185/ https://ncbi.nlm.nih.gov/pubmed/28686074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2017.1345391 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|